63 patients with moderate to severe depression were divided into two groups: escitalopram alone or escitalopram with benzodiazepines.
Clinical progress was measured using the Montgomery-Åsberg Depression Rating Scale (MADRS) at baseline, 4 weeks, and 8 weeks.
Reductions below MADRS score <12 indicated remission, while a 50% reduction from baseline marked response.
In 51 patients that were analyzed, addition of benzodiazepines to escitalopram significantly increased the response and remission rates compared to escitalopram alone.
The combination therapy was well-tolerated, with no significant adverse effects reported.
In summary, Benzodiazepines as add on therapy to antidepressants act more effectively in management of depression associated anxiety and sleep disturbances..
Dar SA, Bhat BA, Jan MM. Addition of benzodiazepines to selective serotonin reuptake inhibitors to optimize treatment of depression: a hospital based study. Int J Res Med Sci, 2018;6(6), 2081–2085.
Chattopadhyay K, Singh AP. Anxiety and its impact on quality of life among urban elderly population in India.
Melaragno AJ. Pharmacotherapy for anxiety disorders: from first-line options to treatment resistance. Focus. 2021;19(2):145-60.
Subramanyam AA, Kedare J, Singh OP, et al. Clinical practice guidelines for Geriatric Anxiety Disorders. Indian J Psychiatry. 2018;60(Suppl 3):S371-S382.
A 34-year-old female patient presented with symptoms of anxiety. The patient had a 10-month history of anxiety symptoms.
A 38-year-old male patient presented with symptoms of anxiety and comorbid depression.
Anxiety disorders, characterised primarily by intense and exaggerated anxiety without real threats, are frequently encountered in the general population.
Anxiety disorders (ADs) have a significant impact on individuals' quality of life and productivity, contributing to substantial economic losses at the national level.